Literature DB >> 15299921

Crystallization of the RNA guanylyltransferase of Chlorella virus PBCV-1.

A J Doherty1, K Håkansson, C K Ho, S Shuman, D B Wigley.   

Abstract

RNA guanylyltransferase, or capping enzyme (E.C. 2.7.7.50) catalyzes the transfer of GMP from GTP to diphosphate-terminated RNA to form the cap structure GpppN. Chlorella virus capping enzyme expressed in E. coli has been purified, treated with GTP and crystallized. X-ray diffraction data have been collected from these crystals as well as for a mercury derivative obtained by soaking the crystals in thimerosal. Selenomethionine RNA guanylyltransferase was purified and crystallized in a similar fashion. The space group is C2221 and the cell parameters are a = 93.3, b = 214.9, c = 105.8 A. Two Hg atoms and two subsets of Se atoms have been localized using difference Patterson and Fourier methods, suggesting that there are two molecules per asymmetric unit.

Entities:  

Year:  1997        PMID: 15299921     DOI: 10.1107/S090744499700231X

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  6 in total

1.  The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure.

Authors:  Moheshwarnath Issur; Brian J Geiss; Isabelle Bougie; Frédéric Picard-Jean; Simon Despins; Joannie Mayette; Sarah E Hobdey; Martin Bisaillon
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

Review 2.  Focus on flaviviruses: current and future drug targets.

Authors:  Brian J Geiss; Hillary Stahla; Amanda M Hannah; Amanda M Gari; Susan M Keenan
Journal:  Future Med Chem       Date:  2009-05       Impact factor: 3.808

3.  Virtual high-throughput screening identifies mycophenolic acid as a novel RNA capping inhibitor.

Authors:  Maude Tremblay-Létourneau; Simon Despins; Isabelle Bougie; Martin Bisaillon
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

4.  Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323.

Authors:  Kristen M Bullard; Rebekah C Gullberg; Elnaz Soltani; J Jordan Steel; Brian J Geiss; Susan M Keenan
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

5.  The immunosuppressive agent mizoribine monophosphate is an inhibitor of the human RNA capping enzyme.

Authors:  Frédéric Picard-Jean; Isabelle Bougie; Satoshi Shuto; Martin Bisaillon
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

6.  Enzymatic synthesis of RNAs capped with nucleotide analogues reveals the molecular basis for substrate selectivity of RNA capping enzyme: impacts on RNA metabolism.

Authors:  Moheshwarnath Issur; Isabelle Bougie; Simon Despins; Martin Bisaillon
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.